XASXTD1
Market cap2mUSD
Dec 19, Last price
0.00AUD
Name
Tali Digital Ltd
Chart & Performance
Profile
TALi Digital Limited, a digital health company, delivers diagnostic and therapeutic solutions to improve cognitive function and behaviour in Australia. The company offers TALi DETECT, a 20-30 minute evidence-based digital screening program comprising cognitive performance tasks to determine how a child's attention skills are developing against their peers; and TALi TRAIN, a digital cognitive training program to improve selective attention and numeracy skills, as well as improvements in inattentive and hyperactive behaviour in some children. It has a strategic licensing agreement with Akili Interactive Labs, Inc for pediatric cognition products. The company was formerly known as Novita Healthcare Limited and changed its name to TALI Digital Limited in December 2019. TALi Digital Limited was incorporated in 2004 and is based in Camberwell, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 2 -92.50% | 27 102.26% | 13 -61.55% | |||||||
Cost of revenue | 940 | 2,403 | 7,302 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (938) | (2,376) | (7,289) | |||||||
NOPBT Margin | ||||||||||
Operating Taxes | (66) | (598) | (614) | |||||||
Tax Rate | ||||||||||
NOPAT | (871) | (1,778) | (6,675) | |||||||
Net income | (3,117) 38.01% | (2,259) -67.44% | (6,936) 42.77% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 3,701 | 2,707 | ||||||||
BB yield | -114.89% | -37.61% | ||||||||
Debt | ||||||||||
Debt current | 505 | 42 | ||||||||
Long-term debt | 924 | |||||||||
Deferred revenue | 1,963 | 1,791 | ||||||||
Other long-term liabilities | 6 | |||||||||
Net debt | (2,127) | (2,485) | (881) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (363) | (2,000) | (4,328) | |||||||
CAPEX | (1) | (818) | (13) | |||||||
Cash from investing activities | (818) | (13) | ||||||||
Cash from financing activities | (504) | 3,956 | 3,458 | |||||||
FCF | (610) | (2,025) | (4,292) | |||||||
Balance | ||||||||||
Cash | 2,127 | 2,990 | 1,847 | |||||||
Long term investments | ||||||||||
Excess cash | 2,127 | 2,989 | 1,847 | |||||||
Stockholders' equity | 2,150 | 5,169 | 3,430 | |||||||
Invested Capital | 23 | 4,648 | 3,885 | |||||||
ROIC | ||||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 3,295,156 | 2,147,518 | 1,199,720 | |||||||
Price | 0.00 -33.33% | 0.00 -75.00% | 0.01 -81.25% | |||||||
Market cap | 3,295 2.29% | 3,221 -55.25% | 7,198 -77.40% | |||||||
EV | 1,168 | 737 | 6,317 | |||||||
EBITDA | (759) | (2,056) | (6,918) | |||||||
EV/EBITDA | ||||||||||
Interest | 11 | |||||||||
Interest/NOPBT |